NDC 61703-343 – Mitoxantrone
Mitoxantrone Hydrochloride 2 mg/mL · Injection, Solution, Concentrate · Intravenous
Product NDC61703-343
Product details
- Brand name
- Mitoxantrone
- Generic name
- Mitoxantrone
- Labeler
- Hospira, Inc.
- Dosage form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Marketing category
- ANDA · ANDA076871
- Marketed since
- April 11, 2006
- Listing expires
- December 31, 2026
- Pharmacologic class
- Topoisomerase Inhibitor
Active ingredients
- Mitoxantrone Hydrochloride 2 mg/mL
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 61703-343-18 | 1 VIAL, MULTI-DOSE in 1 CARTON (61703-343-18) / 10 mL in 1 VIAL, MULTI-DOSE | Apr 11, 2006 |
| 61703-343-65 | 1 VIAL, MULTI-DOSE in 1 CARTON (61703-343-65) / 12.5 mL in 1 VIAL, MULTI-DOSE | Apr 11, 2006 |
| 61703-343-66 | 1 VIAL, MULTI-DOSE in 1 CARTON (61703-343-66) / 15 mL in 1 VIAL, MULTI-DOSE | Apr 11, 2006 |
Recalls mentioning this NDC
- D-0433-2015 Apr 15, 2015 · Class I
Failed Stability Specifications: Product is subpotent and has out of specification known and unknown impurities.
Other mitoXANTRONE products
- 71288-178 Mitoxantrone Hydrochloride 2 mg/mL · Injection, Solution, Concentrate · Meitheal Pharmaceuticals Inc.
- 71288-179 Mitoxantrone Hydrochloride 2 mg/mL · Injection, Solution, Concentrate · Meitheal Pharmaceuticals Inc.
- 63323-132 Mitoxantrone Hydrochloride 2 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC